UnknownNot Applicable

On-table Renal Perfusion Evaluation Renal Artery Stenosis or Obstruction

China30 participantsStarted 2018-04-09

Plain-language summary

1. Evaluate the feasibility for the on-table evaluation of the renal perfusion by using Syngo Dyna Parenchymal Blood Volume(PBV) Body; 2. Explore the clinical benefits of this application during procedure to help the physician to determine the procedure endpoint.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Renal artery stenosis ≥ 60% and \< 100% by doppler ultrasonography, CT angiography or magnetic resonance angiography; * Target kidney remains functional (GFR determined); * The length of target kidney is \>8cm; * Resistance index tested by doppler ultrasonography \<0.8; * Comply with the protocol Exclusion Criteria: * Severe cardiopulmonary insufficiency, hepatic dysfunction, renal inadequacy and clotting mechanism abnormality; * Pregnancy or lactation; * History of renal artery surgery; * Allergy of contrast agent; * Other known reason nonischemic kidney disease

What they're measuring

Glomerular Filtration Rate

Timeframe: Change from Baseline Glomerular Filtration Rate at 3 months

Trial details

NCT IDNCT03530748

SponsorShanghai Zhongshan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-06-09

Contact for this trial

Zhenyu Shi, PhD

021 6404 1990 maxshizhenyu@163.com

View on ClinicalTrials.gov More Renal Artery Stenosis trials